+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
DOLPHMED DOLPHMED

Dolphin Medical Services Share Price

 
297.47% Gain from 52W Low

 

Dolphin Medical Services live price: ₹7.87. It opened at ₹8 vs previous close ₹8; intraday high/low: ₹9/₹8. The 50 & 200 DMA stand at ₹5.00/₹3.20.

Dolphin Medical Services Performance

  • Today's Low
  • ₹8
  • Today's High
  • ₹9
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹10
  • Open Price₹8
  • Previous Close₹8
  • Volume108,141
  • 50 DMA₹5.00
  • 100 DMA₹3.90
  • 200 DMA₹3.20

Dolphin Medical Services Chart

Investment Returns

  • Over 1 Month -9.44%
  • Over 3 Month + 39.79%
  • Over 6 Month + 159.74%
  • Over 1 Year + 226.56%

Smart Investing Starts Here Start SIP with Dolphin Medical Services for Steady Growth!

Invest Now

Dolphin Medical Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 194.2
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 12
  • P/B Ratio
  • 1.2
  • Average True Range
  • 0.4
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.3
  • RSI
  • 70.77
  • MFI
  • 47.94

Latest Stock News Updates

Dolphin Medical Services Ltd - 526504 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

Ms. Vaishnavi Sharma, Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.

Dolphin Medical Services Ltd - 526504 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Ms. Vaishnavi Sharma, Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.

Dolphin Medical Services Ltd - 526504 - Updates on Open Offer (Identified Date)

Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has informed BSE regarding the identified date for the purpose of determining the names of the shareholders to whom the Letter of Offer would be sent is fixed as July 17, 2026.In compliance with regulation 18(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011, the Identified Date is for the purpose of determining the names of the shareholders as on such date to whom the Letter of Offer would be sent.

Dolphin Medical Services Financials

Dolphin Medical Services Technicals

EMA & SMA

Current Price
₹7.87
-0.41 (-4.95%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹6.80
  • 50 Day
  • ₹5.00
  • 100 Day
  • ₹3.90
  • 200 Day
  • ₹3.20

Resistance and Support

8.12 Pivot Speed
  • R3 9.10
  • R2 8.80
  • R1 8.40
  • S1 7.60
  • S2 7.40
  • S3 6.90

Dolphin Medical Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-16 Audited Results
2026-04-22 Others Inter-alia, to consider 1. Appointment of Mr KOLACHALAMA SAIKUMAR, Smt SRUJANA SIDDHANI, Mr NARENDRA SEENAKARKERA & Others as Independent Director. 2. Other business matters.
2026-02-12 Others
2026-02-06 Quarterly Results (Revised)
2025-11-11 Quarterly Results

Dolphin Medical Services Shareholding Pattern

73.56%
26.44%
0%

About Dolphin Medical Services

Dolphin Medical Services is in the business of diagnostics and other allied services. View More
  • NSE Symbol
  • DOLPHMED
  • BSE Symbol
  • 526504
  • Executive Director,Managing Director,Chief Executive Officer
  • G V Mohan Prasad
  • ISIN
  • INE796B01013

Similar Stocks to Dolphin Medical Services

Dolphin Medical Services FAQs

Dolphin Medical Services share price is ₹7 As on 27 July, 2026 | 00:34

The Market Cap of Dolphin Medical Services is ₹11.9 Cr As on 27 July, 2026 | 00:34

The P/E ratio of Dolphin Medical Services is 194.2 As on 27 July, 2026 | 00:34

The PB ratio of Dolphin Medical Services is 1.2 As on 27 July, 2026 | 00:34

The 52 week High & Low of Dolphin Medical Services is ₹9.6/₹2 respectively As on 27 July, 2026 | 00:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23